Jennifer Zeitler
About Jennifer Zeitler
Jennifer Zeitler serves as the Regulatory Affairs Manager at Sangamo Therapeutics, Inc. in Brisbane, CA, a position she has held since 2021, and she has a background in genome editing research from her studies at the University of California, Berkeley.
Work at Sangamo Therapeutics
Jennifer Zeitler has been serving as the Regulatory Affairs Manager at Sangamo Therapeutics, Inc. since 2021. Located in Brisbane, California, she has accumulated three years of experience in this role. Her responsibilities include overseeing regulatory submissions and ensuring compliance with applicable regulations in the biopharmaceutical industry.
Education and Expertise
Jennifer Zeitler studied at the University of California, Berkeley, from 2001 to 2007, where she gained a solid foundation in her field. Her educational background supports her expertise in regulatory affairs and contributes to her effectiveness in managing regulatory processes within the biopharmaceutical sector.
Background
Jennifer Zeitler has a background in regulatory affairs, with a focus on biopharmaceuticals. Her role at Sangamo Therapeutics involves navigating complex regulatory landscapes and contributing to the advancement of innovative therapies. Her experience in the industry enhances her capability to manage regulatory challenges.
Achievements
Jennifer Zeitler contributed to a publication that discusses first-in-human in vivo genome editing using AAV-zinc finger nucleases for treating mucopolysaccharidosis I/II and hemophilia B. This work highlights her involvement in significant research initiatives within the field of genome editing and regulatory affairs.